's stock had its "sell (e+)" rating reaffirmed by equities researchers at
Weiss Ratings in a research report issued to clients and investors on Friday,
Weiss Ratings reports.
Edap Tms Trading Down 0.8%
Edap Tms stock opened at $2.38 on Friday. The company has a 50 day moving average price of $2.24 and a 200 day moving average price of $1.86. Edap Tms has a 52 week low of $1.21 and a 52 week high of $3.08. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.05 and a current ratio of 1.51. The firm has a market capitalization of $88.99 million, a price-to-earnings ratio of -3.90 and a beta of -0.15.
Hedge Funds Weigh In On Edap Tms
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Cetera Investment Advisers boosted its stake in shares of Edap Tms by 33.9% during the 1st quarter. Cetera Investment Advisers now owns 75,000 shares of the medical equipment provider's stock valued at $147,000 after buying an additional 19,000 shares during the period. Simplicity Wealth LLC acquired a new stake in shares of Edap Tms during the 2nd quarter valued at $54,000. Sage Mountain Advisors LLC acquired a new stake in shares of Edap Tms during the 2nd quarter valued at $165,000. Scoggin Management LP acquired a new stake in shares of Edap Tms during the 1st quarter valued at $686,000. Finally, Banque Transatlantique SA boosted its stake in shares of Edap Tms by 7,063.7% during the 1st quarter. Banque Transatlantique SA now owns 730,699 shares of the medical equipment provider's stock valued at $1,324,000 after buying an additional 720,499 shares during the period. Institutional investors and hedge funds own 62.74% of the company's stock.
About Edap Tms
(
Get Free Report)
EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Edap Tms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Edap Tms wasn't on the list.
While Edap Tms currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
